Delivery Order SPE2D018D0005-SPE2D323F040A
Award Date 6/28/23
Potential Completion Date 7/3/23
Potential Value $5.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Ortho-Clinical Diagnostics Inc. has been awarded a $1,037.23 firm fixed price delivery order against an unidentified contract vehicle by the Defense Logistics Agency Troop Support Medical to provide 4561341953, described as 150ml vials of monoclonal anti-D reagent, for use at a place of performance in Raritan, New Jersey. The delivery order has a period of performance from June 26, 2023 through June 29, 2023 to supply the specified medical reagents to the Department of Defense logistics...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract on September 5, 2025, by the Defense Medical Supply Chain for the supply of Reagent Anti-D Bioclone 150mL Monoclonal with a ceiling value of $1,037.23. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was used for this award, indicating it was competed openly. The contract...
- Ortho-Clinical Diagnostics Inc. was awarded a $4,115.02 fixed-price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract vehicle. The prime contractor will provide 15 boxes containing 10 milliliters each of anti-D biocloone to the Defense Logistics Agency, the logistics combat support agency within the U.S. Department of Defense, by September 6, 2023. The place of performance is Ortho-Clinical Diagnostics' facility in Raritan,...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order valued at $1,037.23 for Reagent Anti-D Bioclone 150ML Monoclonal on September 10, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price contract was issued without a set-aside designation, indicating open competition. The contract is funded by the Defense Medical Supply Chain, a defense-focused federal agency, with performance taking place at the contractor's...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,037 to Ortho-Clinical Diagnostics Inc. for the supply of 150ml monoclonal anti-D reagents. The reagents will be delivered to the prime contractor's facility in Raritan, New Jersey by July 11, 2023 to support DLA's medical supply needs. No subcontractors or set aside designations were identified in the award information. DLA Troop Support Medical routinely issues contracts and...
- Ortho-Clinical Diagnostics Inc. has been awarded a $258 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 10 ml vials of anti-human rabbit IgG reagent. The prime contractor will deliver the specified reagents to a location in Raritan, New Jersey by September 12, 2023 under the firm-fixed-price contract. No subcontractors or set-aside designations were indicated. The Defense Logistics Agency Troop Support...
- Ortho-Clinical Diagnostics Inc. was awarded a $43,040 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract. The prime contractor will provide approximately 10 ml of anti-IgG reagent to the agency over a three-day period of performance in August 2023. The firm fixed price order was awarded to Ortho-Clinical Diagnostics Inc. for supply of the specified medical reagent to support the Defense Logistics Agency Troop Support...
- Ortho-Clinical Diagnostics Inc. has been awarded a $2,650.70 fixed-price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract. The prime contractor will provide 15 boxes containing 10 milliliters each of an anti-A bioclone product to the Defense Logistics Agency by August 4, 2023. Performance will take place at Ortho-Clinical Diagnostics' facility in Raritan, New Jersey. No subcontractors or set-aside designations were...
- Ortho-Clinical Diagnostics Inc. was awarded a $784.05 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 150 milliliters of anti-IgG C3d reagent to the agency. Performance will take place at the prime contractor's facility in Raritan, New Jersey over a period of three days from August 15-18, 2023. The firm fixed price contract was awarded by the Defense Logistics Agency Troop Support Medical to support its medical...
- Ortho-Clinical Diagnostics Inc. was awarded a $784.05 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 150 milliliters of anti-IgG C3d reagent to the agency. Performance will take place at the prime contractor's facility in Raritan, New Jersey over a period of five days concluding on August 15, 2023. The firm fixed price contract was awarded on August 10, 2023 by the Defense Logistics Agency Troop Support...
- SPE2D018D0005Indefinite Delivery Contract
- SPE2D018D0005-SPE2D323F040ADelivery Order
Ortho-Clinical Diagnostics Inc. was awarded a $5,186.15 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 150ml of monoclonal anti-D reagent to the agency. The place of performance will be the prime contractor's facility located in Raritan, New Jersey. The period of performance is short, spanning from June 28 to July 3, 2023. This firm-fixed-price order supports the agency's medical supply needs and will deliver the requested reagents on an expedited timeline before the base IDIQ contract expires. No subcontractors or set-aside designations were identified in the award documentation.
Generated 12/18/23, 2:46 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 6/28/23 |